Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

This study reports that a community program in Desa Cibiru Wetan led to a significant increase in knowledge about utilizing peppermint leaves from TOGA cultivation as an ingredient in hair masks, which may enhance local economic opportunities.

This study identified significant morphological and sensory differences among 19 genotypes of Ziziphus jujube Mill. grown at the Slovak University of Agriculture, suggesting potential applications in organic agriculture and other practices.

In a real-world study, baricitinib was effective for scalp, eyebrow, and eyelash regrowth in patients with alopecia areata, showing clinically meaningful improvements as early as 3 months and increasing up to 12 months; satisfaction and perceived improvement were also high among participants.

In this report, a 58-year-old woman with ocular myasthenia gravis experienced complete resolution of symptoms and hair regrowth after six months of treatment with the JAK inhibitor baricitinib, highlighting a potential new therapeutic approach for this condition.

In this randomized controlled trial, researchers found that after six months of treatment, oral baricitinib was significantly more effective than methotrexate for improving hair regrowth in patients with severe alopecia areata, as measured by the Severity of Alopecia Tool score.

This review discusses the biologically active compounds in Maxillariinae orchids, highlighting 62 semiochemicals with medical potential, but reports no new clinical findings.

This study reported on 23 medicinal plant species used in Ben M'hidi, El-Tarf, Algeria, providing ethnobotanical insights into their traditional therapeutic applications.

Fusarium sp. strain K-23 helps Arabidopsis plants grow better in salty soil by promoting root hair growth.

This source reports that baricitinib significantly promotes hair regrowth in patients with severe alopecia areata, particularly those with a SALT score of 50 or higher, in clinical trials.

This study observed that baricitinib treatment led to significant improvement in a patient's alopecia areata symptoms and suggests further clinical trials to explore its potential as a treatment.

This review assessed randomised clinical trials on the efficacy and safety of topical and systemic JAK inhibitors for alopecia areata, finding significant hair coverage improvement with ritlecitinibe and baricitinibe, though prolonged treatment is often needed to maintain results.

This study documented the indigenous uses of 68 medicinal plant species for food and beverages across three ethnic communities in Southwest Pakistan, with implications for sustainable development and cross-cultural understanding.

In this study, the fixed oil extracted from Apeiba tibourbou seeds showed potential analgesic and anti-inflammatory properties, with prominent constituents including omega-3 and omega-6 fatty acids.

This study found that supplementing Angora goats with whole field bean seeds postpartum did not prevent weight and body condition losses but was associated with improved mohair growth and kid weight gain, likely due to better nutrient partitioning towards lactation and hair growth.

This review discusses the approved uses and adverse reactions of JAK inhibitors, noting their importance in treating various conditions but highlighting significant hematological and immunological risks.

The researchers reviewed multiple studies and found that baricitinib, a JAK inhibitor, generally improved the condition of patients with severe alopecia areata, with minimal side effects.

In this review, researchers highlighted E. alba (bhringraj) for its traditional uses in treating liver and hair growth issues, skin conditions, and digestive health, emphasizing its purported benefits like hair growth promotion and liver function enhancement.

In this research, the authors reported that long-term treatment with the JAK1/JAK2 inhibitor baricitinib effectively maintains hair regrowth in patients with severe alopecia areata and may gradually improve outcomes for partial responders over 104 weeks, without increasing side effect incidence.

This research highlights the various traditional uses of E. alba (bhringraj), noting its benefits for hair growth, liver function, and skin conditions such as eczema and pruritis, though results are not reported in this abstract.

This study developed a protocol for callus induction and found that certain hormone concentrations enhance the production of flavonoids, phenols, and terpenes in Bituminaria bituminosa.

Baricitinib stops hair loss and promotes regrowth in alopecia areata.

This study reported that rosemary is widely used among Jordanians for various purposes, such as improving hair condition and addressing gastrointestinal issues, with younger participants showing higher knowledge about its benefits and uses.

This study explored the ethnopharmacological use of traditional plants by the Amarasi community in Indonesia for treating dandruff and hair loss, identifying 18 plants with potential anti-dandruff and hair-nourishing properties used by local healers for scalp care.

This case report highlights that Baricitinib led to significant hair regrowth and resolution of atopic dermatitis symptoms in a 22-year-old female with coexisting autoimmune conditions.

This announcement discusses the recent FDA approval of baricitinib for treating severe alopecia areata in adults and reports no new clinical results.

In this study, the wood essential oil of *Juniperus morrisonicola* exhibited significant anti-inflammatory activity, notably inhibiting nitric oxide production in stimulated macrophages, and showed cytotoxic effects against liver cancer cells, suggesting its potential for drug development and eco-friendly applications.